Pelosi Unveils Drug Pricing Bill, W&M Releases Price Report

House Democrats introduced a bill to stem high and rising drug prices, as well as redesign the Part D benefit. This follows a range of proposals from the Trump Administration and a bipartisan proposal by the Senate Finance Committee. The House bill draws on both and adds a government negotiation for high-priced drugs. Click to read more.

Healthcare Investment Index 2019

In the second year of BRG Healthcare Transactions and Strategy’s annual Investment Index, we have continued to update the index by retrospectively tallying the number and type of deals we are aware of over the past eighteen months and prospectively surveying 133 investors from 85 organizations in August 2019 about areas of interest over the next year. These two sets of information provide a sense of trends in private equity healthcare investment. Click here to read the full report.

Number of Uninsured Americans Rises

The number of Americans lacking health insurance ticked up slightly last year, marking the first annual increase in the uninsured rate in nearly a decade, the US Census Bureau reported last Tuesday. The uninsured rate rose from 7.9% in 2017 to 8.5% last year, amounting to nearly 2 million more uninsured people. Click to read more.

Uniform VBP for Post-Acute Providers Back on MedPAC Agenda

Based on a Congressional mandate, MedPAC continues to explore a uniform value incentive program across post-acute sectors, where quality incentives tied to reimbursement have lagged other provider types. MedPAC’s model could form the basis for future changes, but not likely in the near term. Click to read more.